Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

MedTech

ApoCell contracts its translational research services with biopharma, academic and government labs, and CROs to develop biomarker assays and process clinical specimens to facilitate which drugs benefit the right patient. This collaborative approach is designed to advance investigational therapies through the regulatory agencies in an accelerated, cost-efficient manner.

Read more ...

Enables Hepatitis C Point-of-Care molecular testing and linkage to care. Cepheid announced the CE-IVD marking of Xpert HCV VL Fingerstick, the first molecular test to detect and quantify hepatitis C Virus (HCV) RNA levels directly from a fingerstick blood sample. Currently, the clinical care pathway for detection of hepatitis C faces many barriers, including complicated multi-step diagnostic algorithms based on antibody screening and RNA confirmation1. These algorithms currently require centralized testing technologies that may result in treatment delays and loss to follow up, and could discourage at-risk populations from accessing testing and receiving care.

Read more ...

Qiagen and NeuMoDx said they have signed a strategic partnership and merger agreement related to the commercialization of a pair of fully integrated PCR-based molecular diagnostic systems. As part of their strategic partnership, Qiagen will initially distribute the NeuMoDx 288 (high-throughput) and NeuMoDx 96 (mid-throughput) systems in Europe and other markets outside the US, where NeuMoDx will continue to market the products.

Read more ...

Acquisition to Accelerate Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Fully-Integrated Surgical Solutions Medtronic, a global player in medical technology, and Mazor Robotics, a pioneer in the field of robotic guidance systems, announced the companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding ordinary shares of Mazor for $58.50 per American Depository Share, or $29.25 (104.80 ILS) per ordinary share, in cash, for a total of approximately $1.64 billion, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired. The boards of directors of both companies have unanimously approved the transaction.

Read more ...

Clara to dramatically boost capabilities of legacy instruments, setting future of AI medical devices. NVIDIA unveiled the NVIDIA Clara platform, a combination of hardware and software that brings AI to the next generation of medical instruments as a powerful new tool for early detection, diagnosis and treatment of diseases.

Read more ...

CRISPR Therapeutics, a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, and ViaCyte, a privately held regenerative medicine company, announced a collaboration focused on the discovery, development, and commercialization of gene-edited allogeneic stem cell therapies for the treatment of diabetes.

Read more ...

Upcoming Events


> Lab-on-a-Chip and Microfluidics World Congress 2018
(October 1 - October 3, Coronado Island, California)

> Precision CRISPR Congress
(October 22 - October 24, London, UK)

> Medical MEMS and Sensors 2018
(November 7 - November 8, Santa Clara, USA)

Presentation

Point of Need Testing & Liquid Biopsy Technology and Market Overview:Challenges, market trends and new solutions
Discover the presentation held by Asma Siari at LOAC Europe 2018, on June 5, 2018, in Rotter...
Convergence of Biosensors and mHealth: application trends and market opportunities
Discover the presentation held by Jérôme Mouly at IEK Forum 2018, on May 22nd 2018, in Tai...
When wearables meet connected healthcare: ready for a disruption?
Discover the presentation held by Benjamin Roussel at Medical Wearables 2018, on May 17th 20...

Access to all our presentations